Mitochondrial oxidative metabolism is central to glucose-stimulated insulin secretion (GSIS). 23 Whether Ca 2+ uptake into pancreatic β-cell mitochondria potentiates or antagonises this process 24 is still a matter of debate. Although the mitochondrial importer (MCU) complex is thought to 25 represent the main route for Ca 2+ transport across the inner mitochondrial membrane, its role 26 in β-cells has not previously been examined in vivo. Here, we inactivated the pore-forming 27 subunit MCUa (MCU) selectively in the β-cell in mice using Ins1Cre-mediated recombination. 28 Glucose-stimulated mitochondrial Ca 2+ accumulation, ATP production and insulin secretion 29 were strongly (p<0.05 and p<0.01) inhibited in MCU null animals (βMCU-KO) in vitro. 30 Interestingly, cytosolic Ca 2+ concentrations increased (p<0.001) whereas mitochondrial 31 membrane depolarisation improved in βMCU-KO animals. Male βMCU-KO mice displayed 32 impaired in vivo insulin secretion at 5 (p<0.001) but not 15 min. post intraperitoneal (IP) 33 injection of glucose while the opposite phenomenon was observed following an oral gavage at 34 5 min. Unexpectedly, glucose tolerance was improved (p<0.05) in young βMCU-KO (<12 35 weeks), but not older animals. We conclude that MCU is crucial for mitochondrial Ca 2+ uptake 36 in pancreatic β-cells and is required for normal GSIS. The apparent compensatory mechanisms 37 which maintain glucose tolerance in βMCU-KO mice remain to be established. 38 39 40
Introduction
excitation system equipped with a Hg/Xe arc lamp with image capture at 0.2 Hz excitation time 139 50 ms). 140 For experiments with tetramethylrhodamine (TMRE), β-cells were loaded with 10nM TMRE 141 in imaging buffer (140 mM NaCl, 3.6 mM KCl, 0.5 mM NaH2PO4, 24 mM NaHCO3 (saturated 142 with CO2), 1.5 mM CaCl2, 0.5 mM MgSO4, 10 mM HEPES and 3 mM glucose) for 45 min. Images were captured at 0.5Hz on a Zeiss Axiovert microscope equipped with a 10X 0.3-0.5 155 NA oil immersion objective, coupled to a Nipkow spinning-disk head (Yokogawa CSU-10) 156 and illuminated at 491nm. Data were analysed using ImageJ with a purpose-designed macro 157 (available upon request). In vitro insulin secretion 159 Insulin secretion assays were performed on islets isolated from male mice (8-10 weeks) (24) . 160 Secreted and total insulin were quantified using a homogeneous time-resolved fluorescence 161 (HTRF) insulin kit (Cisbio) in a PHERAstar reader (BMG Labtech, UK) following the 162 manufacturer's guidelines. Data are presented as secreted insulin/insulin content. Voltage-dependent calcium channel (VDCCs) currents were recorded from dispersed mouse 173 β-cells as previously described (22) 186 To ablate MCU from pancreatic β-cells, animals bearing alleles in which LoxP sites flanked 187 exons 11 and 12 of the Mcu gene were generated (See Materials and Methods) and crossed to 188 mice harbouring Cre recombinase inserted at the Ins1 locus (16) (Fig. 1A) . This strategy (25). 196 We next explored the consequences for glucose-stimulated insulin secretion in isolated βMCU-197 KO islets. In perifusion experiments, βMCU-KO islets displayed a significant blunting in the 198 secretory response to elevated glucose, with the attenuation in insulin release most evident at 199 high glucose concentrations (17 mM), as determined at the first peak (p<0.05; Fig. 1C ). These deployed together to bypass glucose regulation of the KATP channel ( Fig. 2C', E') . 216 Mcu deletion attenuated glucose-stimulated increases in [Ca 2+ ]mt in dissociated islets ( Fig. 2A- with KCl was largely maintained in βMCU-KO. The [Ca 2+ ]mt was also assessed in whole islets 220 using mito Pericam where a trend towards reduced mitochondrial Ca 2+ uptake was observed 221 ( Fig. 2C-D) . To determine whether the impaired [Ca 2+ ]mt changes in βMCU-KO β-cells may 222 simply reflect altered cytosolic Ca 2+ ([Ca 2+ ]cyt) dynamics, the latter were also explored using 223 the Ca 2+ -sensitive dye (Cal-520) in whole islets. Interestingly, [Ca 2+ ]cyt increases in whole 224 βMCU-KO islets were significantly increased in response to glucose in comparison to WT 225 animals (AUC; p<0.001; Fig. 2E, F) . Given the significant reduction in GSIS observed in βMCU-KO islets in vitro and despite 230 improved cytosolic Ca 2+ dynamics, we next sought to determine whether an alteration in 231 glucose metabolism might contribute to the attenuated insulin secretion. To address this, we 232 utilised real-time fluorescence imaging of the ATP sensor, Perceval (9). A rise in the ATP:ADP 233 ratio was prompted in control β-cells by a step increased in glucose from 3 to 17 mM (9). This 234 change was significantly blunted in Mcu null β-cells (AUC; p<0.05; Fig. 3A, B) . This was 235 accompanied by a potentiation in the increase in mitochondrial membrane potential (Δψm), as 236 assessed by monitoring TMRE fluorescence in βMCU-KO mouse β-cells (AUC700-720s; 237 p<0.05; Fig. 3C, D) . 238 Altered ATP production in response to high glucose is expected to affect the activity of KATP 239 channels (27) . Assessed in single β-cells using perforated patch-clamp electrophysiology (9), 240 the extent of membrane potential depolarisation in response to a step increase in extracellular 241 glucose from 3 to 17 mM did not differ significantly between βMCU-KO and control β-cells, 242 although there was a trend towards weaker depolarisation in KO cells ( Fig. 3E, F) . VDCC 
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Mcu ablation from pancreatic β-cells attenuates GSIS in vitro
226
MCU deletion from pancreatic β-cells reduces mitochondrial ATP production and
253
Loss of MCU from pancreatic β-cells does not alter body mass or fed glycaemia but
254 impairs GSIS in vivo 255 We next explored the role of β-cell MCU in the control of insulin secretion and in vivo glucose 256 homeostasis. βMCU-KO animals displayed normal growth and weight changes from 6 to 24 257 weeks ( Fig. S1A) . However, male βMCU-KO mice showed a slight, but significant, increase 258 (p<0.05) in weight gain from 20-24 weeks. We observed no differences in random fed blood 259 glucose levels between βMCU-KO and control animals at all ages examined ( Fig. S1B) . No 260 genotype-dependent differences in the above metabolic parameters were observed in female 261 mice at any age ( Fig. S1C, S1D; Fig. S2A-D) . 262 Glucose tolerance was investigated in βMCU-KO and WT mice by intraperitoneal injection of 263 1g/kg body weight glucose (IPGTT) at 8, 12, 16 and 24 weeks of age. A small but significant 264 improvement in glucose tolerance was observed in male βMCU-KO mice vs controls at 8 265 (p<0.001) or 12 (p<0.05) weeks of age ( Fig. 5A, B) . Older male animals displayed unaltered 266 glucose tolerance ( Fig. 5C, D) vs WT mice.
267
To assess GSIS in vivo, 8-10 week-old male mice were challenged with 3g/kg glucose and 268 plasma insulin sampled at 0, 5, 15 and 30 min. (Fig. 6A, B) . Although improved glucose 269 tolerance was observed in βMCU-KO animals post 15 min. IP administration (Fig. 6A) , a 270 dramatic reduction (p<0.001) in insulin release was observed 5 min. post-glucose injection 271 15 ( Fig. 6B) . βMCU-KO animals also displayed improved oral glucose tolerance at 15 and 30 272 min. post-oral gavage ( Fig. 6C; p<0 .05), increased insulin secretion at 5 min. ( Fig. 6D;   273 p<0.05) vs WT littermates. No differences in intraperitoneal insulin tolerance ( Fig. 6 E, F) or 274 c-peptide levels (not shown) were observed between WT and KO mice.
275
Finally, to impose a metabolic stress, βMCU-KO mice and control littermates were maintained 276 on a HFHS diet and subjected to the same tests as in (Fig. 6A, B) . Again, no differences in 277 glycaemia or insulin secretion were observed between phenotypes (Fig. S3A, B) . No genotype-278 dependent differences in c-peptide secretion were apparent (not shown). 
308
Importantly, our observations support the view that Ca 2+ accumulation by mitochondria 309 stimulates ATP consumption, consistent with a reduction in glucose-stimulated ATP:ADP ratio 310 in the KO mouse (6). Additionally, mitochondrial membrane potential was increased, 311 particularly in glucose-stimulated conditions, in dissociated islets from KO vs WT mice. An 312 increase in Δψm in the face of lowered cytosolic ATP:ADP is consistent with a decrease in 313 F1/F0ATPase activity (38) (Fig.7B) , an enzyme previously reported to be Ca 2+ regulated in 
329
Extending to the in vivo setting, the current and earlier (9; 15) in vitro data demonstrating roles 330 for MCU in the control of glucose-induced insulin secretion, we show that insulin secretion is 331 impaired in βMCU-KO vs control mice 5 min. post to intraperitoneal injection of glucose.
332 Surprisingly, however, insulin secretion post-oral gavage was elevated in KO mice at 5 min.
333 perhaps suggesting that gut-derived factors such as the gastric inhibitory polypeptide and 334 glucagon-like peptide-1 (GIP and GLP-1) are partially responsible for the enhanced glucose-335 stimulated insulin secretion from the β-cells (43). Future studies will be necessary to explore 336 this possibility.
337
Interestingly, earlier studies inactivating MCU globally in the mouse, or in selected tissues, mechanisms are likely to emerge after that period to maintain normal cellular energy 344 homeostasis and signalling in vivo. One intriguing possibility, which may be of particular 345 relevance to the nutrient-responsive β-cell, is that the mitochondrial Na + -Ca 2+ exchanger 346 NCLX operates in the reverse mode at low Δψm, thus allowing Ca 2+ influx (45) to provide a 347 compensatory mechanism for the loss of MCU.
348
The findings here also provide evidence of a role for additional, mitochondrially-derived 349 metabolic signals whose generation depends upon mitochondrial Ca 2+ uptake and which serve 371 The authors declare that they have no conflicts of interest with the contents of this article. had full access to all the data in the study and takes responsibility for the integrity of the data 397 and the accuracy of the data analysis. 
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